title: Are new drugs cost-effective for patients undergoing ambulatory surgery?
authors.forename: P F
authors.initials: PF
authors.lastname: White
authors.forename: M F
authors.initials: MF
authors.lastname: Watcha
mesh_terms: D000556:Ambulatory Surgical Procedures; D000700:Analgesics / Q000191:economics*; D003362:Cost-Benefit Analysis; D006801:Humans; D020910:Ketorolac; D017294:Ondansetron / Q000191:economics*; D014046:Tolmetin / Q000031:analogs & derivatives* / Q000191:economics; D014481:United States
chemical_list: D000700:Analgesics; D017294:Ondansetron; D014046:Tolmetin; D020910:Ketorolac